|载体标签:||V5 Epitope Tag （C-端）|
pLenti6.3/V5-DEST载体描述 Invitrogen's pLenti6.3⁄V5-DEST Gateway Vector Kit is part of our ViraPower HiPerform Lentiviral Gateway Expression Kit . The pLenti6.3⁄V5-DEST Gateway Vector Kit contains the Gateway-adapted ViraPower HiPerform lentiviral expression vector, pLenti6.3⁄V5-DEST for easy recombination-based cloning and high-level expression of a target gene in dividing and non-dividing mammalian cells. The pLenti6.3⁄V5-DEST vector is equipped with two key genetic elements, making it a HiPerform vector: the Woodchuck Posttranscriptional Regulatory Element (WPRE) and the central Polypurine Tract (cPPT) sequence from the HIV-1 integrase gene to produce at least 4-fold increase in protein expression compared to vectors lacking these elements. pLenti6.3/V5-DEST载体优点 • Stable expression • Long-term experiments • Accurate titer of functional virus • Flexible and versatile Gateway® recombination cloning technology pLenti6.3/V5-DEST载体特征 • HiPerform™ WPRE and cPPT elements • CMV promoter • V5 epitope tag at C terminus • Blasticidin selection Gateway技术 The Gateway Technology is a universal cloning method that takes advantage of the site-specific recombination properties of bacteriophage lambda (Landy, 1989) to provide a rapid and highly efficient way to move your gene of interest into multiple vector systems. To express your gene of interest using Gateway Technology, simply: 1. Generate entry clones containing your promoter and gene(s) of interest. 2. Generate an expression clone by performing an LR recombination reaction between the entry clone(s) and pLenti6.3/V5-DEST). 3. Transfect your expression clone into cells of your choice to transiently or stably express your gene of interest. To fit all of your expression needs, Invitrogen offers state-of-the-art Gateway destination vectors for expression in E. coli, insect, yeast, or mammalian cells, as well as for production of native protein or N- or C-terminal fusion proteins. All Gateway destination vectors have attR sites for recombination with any attL-flanked fragment, regardless of whether it is an entry clone or an Ultimate ORF Clone. The following table lists a variety of available destination vectors. Additional materials required, available separately: Gateway entry clone, appropriate Gateway LR Clonase enzyme mix, and reaction buffer. 所需材料 在着手开始实验前你需要准备一下材料： Gateway entry clone, appropriate Gateway LR Clonase enzyme mix, and reaction buffer. • Purified plasmid DNA of your entry clone(s) (10 fmoles each) • pLenti6.3/V5-DEST (20 fmoles) • LR Clonase II Plus enzyme mix (keep at –20°C until immediately before use) • 1X TE Buffer, pH 8.0 (10 mM Tris-HCl, pH 8.0, 1 mM EDTA) • 2 μg/μL Proteinase K solution (supplied with the enzyme mix; thaw and keep on ice until use) • Appropriate competent E. coli host and growth media for expression • S.O.C. Medium • LB agar plates containing 100 μg/mL ampicillin 进行LR重组反应 值得注意的事项： If you use E. coli cells with a transformation efficiency of ≥1 × 108 cfu/μg, a typical LR reaction should give >5,000 colonies if the entire reaction is transformed and plated. For multiple fragment reactions, typical numbers of colonies (per 10 μL LR reaction) are: • 2-fragment recombination reaction: 2,000–15,000 • 3-fragment recombination reaction: 1,000–5,000 • 4-fragment recombination reaction: 50–500 Confirming the Expression Clone The ccdB gene mutates at a very low frequency, resulting in a very low number of false positives. True expression clones will be ampicillin-resistant and chloramphenicol-sensitive. Transformants containing a plasmid with a mutated ccdB gene will be both ampicillin- and chloramphenicol-resistant. To check your putative expression clone, test for growth on LB plates containing 30 μg/mL chloramphenicol. A true expression clone will not grow in the presence of chloramphenicol. Sequencing To confirm that your gene of interest is in frame with the C-terminal V5 epitope, you may sequence your expression construct, if desired. We suggest using the following primer sequences.